Magrinelli Francesca, Mehta Sahil, Di Lazzaro Giulia, Latorre Anna, Edwards Mark J, Balint Bettina, Basu Purba, Kobylecki Christopher, Groppa Sergiu, Hegde Anaita, Mulroy Eoin, Estevez-Fraga Carlos, Arora Anshita, Kumar Hrishikesh, Schneider Susanne A, Lewis Patrick A, Jaunmuktane Zane, Revesz Tamas, Gandhi Sonia, Wood Nicholas W, Hardy John A, Tinazzi Michele, Lal Vivek, Houlden Henry, Bhatia Kailash P
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Mov Disord. 2022 Jan;37(1):148-161. doi: 10.1002/mds.28807. Epub 2021 Oct 8.
Complex parkinsonism is the commonest phenotype in late-onset PLA2G6-associated neurodegeneration.
The aim of this study was to deeply characterize phenogenotypically PLA2G6-related parkinsonism in the largest cohort ever reported.
We report 14 new cases of PLA2G6-related parkinsonism and perform a systematic literature review.
PLA2G6-related parkinsonism shows a fairly distinct phenotype based on 86 cases from 68 pedigrees. Young onset (median age, 23.0 years) with parkinsonism/dystonia, gait/balance, and/or psychiatric/cognitive symptoms were common presenting features. Dystonia occurred in 69.4%, pyramidal signs in 77.2%, myoclonus in 65.2%, and cerebellar signs in 44.6% of cases. Early bladder overactivity was present in 71.9% of cases. Cognitive impairment affected 76.1% of cases and psychiatric features 87.1%, the latter being an isolated presenting feature in 20.1%. Parkinsonism was levodopa responsive but complicated by early, often severe dyskinesias. Five patients benefited from deep brain stimulation. Brain magnetic resonance imaging findings included cerebral (49.3%) and/or cerebellar (43.2%) atrophy, but mineralization was evident in only 28.1%. Presynaptic dopaminergic terminal imaging was abnormal in all where performed. Fifty-four PLA2G6 mutations have hitherto been associated with parkinsonism, including four new variants reported in this article. These are mainly nontruncating, which may explain the phenotypic heterogeneity of childhood- and late-onset PLA2G6-associated neurodegeneration. In five deceased patients, median disease duration was 13.0 years. Brain pathology in three cases showed mixed Lewy and tau pathology.
Biallelic PLA2G6 mutations cause early-onset parkinsonism associated with dystonia, pyramidal and cerebellar signs, myoclonus, and cognitive impairment. Early psychiatric manifestations and bladder overactivity are common. Cerebro/cerebellar atrophy are frequent magnetic resonance imaging features, whereas brain iron deposition is not. Early, severe dyskinesias are a tell-tale sign. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
复杂性帕金森综合征是晚发型PLA2G6相关神经变性中最常见的表型。
本研究旨在对有史以来最大队列中PLA2G6相关帕金森综合征的表型和基因型进行深入特征分析。
我们报告了14例新的PLA2G6相关帕金森综合征病例,并进行了系统的文献综述。
基于来自68个家系的86例病例,PLA2G6相关帕金森综合征表现出相当独特的表型。常见的首发症状为青年起病(中位年龄23.0岁),伴有帕金森综合征/肌张力障碍、步态/平衡障碍和/或精神/认知症状。71.9%的病例出现早期膀胱过度活动症。76.1%的病例有认知障碍,87.1%有精神症状,其中20.1%以精神症状为唯一首发症状。帕金森综合征对左旋多巴有反应,但常伴有早期且往往严重的运动障碍。5例患者受益于脑深部电刺激。脑磁共振成像结果包括大脑萎缩(49.3%)和/或小脑萎缩(43.2%),但仅有28.1%有明显的脑矿物质沉积。所有进行检查的患者突触前多巴胺能终末成像均异常。迄今已有54种PLA2G6突变与帕金森综合征相关,包括本文报道的4种新变异。这些突变主要为非截断性突变,这可能解释了儿童期和晚发型PLA2G6相关神经变性的表型异质性。在5例已故患者中,中位病程为13.0年。3例患者的脑病理显示路易体和tau病理混合存在。
双等位基因PLA2G6突变导致早发型帕金森综合征,伴有肌张力障碍、锥体束征和小脑征、肌阵挛及认知障碍。早期精神表现和膀胱过度活动症很常见。大脑/小脑萎缩是常见的磁共振成像特征,而脑铁沉积并非如此。早期严重运动障碍是一个明显特征。© 2021作者。《运动障碍》由Wiley Periodicals LLC代表国际帕金森和运动障碍协会出版。